Literature DB >> 28167992

Giant Chondroma of the Saddle Area: Case Report and Literature Review.

Lubin Qiu1, Yongjun Zhu1, Haijun Wang2, Yatang Wang1, Qiang Wu3, Jianming Yang1.   

Abstract

A 63-year-old man presented with sexual dysfunction of 6-year duration, 5-year history of bilateral vision loss, and left nasal obstruction for 3 years. Brain computed tomography and magnetic resonance imaging showed a large mass lesion in the saddle area and extending upward to the dorsum sellae, bilateral cavernous sinus, and suprasellar region, and down into the sphenoid sinus and nasal cavity; the optic nerves and optic chiasm were elevated upward and compressed. Endocrine tests indicated that all serum level of anterior pituitary hormones decreased. The preoperative diagnosis included invasive pituitary adenoma, chordoma, osteosarcoma, chondrosarcoma, and craniopharyngioma. The tumour was subtotally removed through transsphenoidal approach. Histopathology examination revealed a chondroma. Postoperatively, the patient was stable and his visual acuity and visual field defect improved and his pituitary function return to normal except for hypothyroidism.

Entities:  

Keywords:  Computed tomography (CT); histology; magnetic resonance (MR); sellar chondroma; transsphenoidal approach

Year:  2013        PMID: 28167992      PMCID: PMC5291066          DOI: 10.3109/01658107.2013.830626

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  52 in total

1.  The Dolenc technique for cavernous sinus exploration (cadaveric prosection). Technical note.

Authors:  H R van Loveren; J T Keller; M el-Kalliny; D J Scodary; J M Tew
Journal:  J Neurosurg       Date:  1991-05       Impact factor: 5.115

2.  Sellar chondroma--case report.

Authors:  A Aoki; K Mori; A Tajima; M Maeda
Journal:  Neurol Med Chir (Tokyo)       Date:  1999-11       Impact factor: 1.742

Review 3.  [Dura mater chondroma. A case report and review of the literature].

Authors:  M Sebbag; V Schmidt; N Leboucq; J Bitoun; P Castan; P Frerebeau
Journal:  J Radiol       Date:  1990 Aug-Sep

4.  Anatomy of the cavernous sinus. A microsurgical study.

Authors:  F S Harris; A L Rhoton
Journal:  J Neurosurg       Date:  1976-08       Impact factor: 5.115

5.  A surgical approach to the cavernous portion of the carotid artery. Anatomical studies and case report.

Authors:  D Parkinson
Journal:  J Neurosurg       Date:  1965-11       Impact factor: 5.115

6.  Intracranial chondroma in a patient with Ollier's disease. Case report.

Authors:  R F Traflet; A R Babaria; G Barolat; H T Doan; C Gonzalez; M M Mishkin
Journal:  J Neurosurg       Date:  1989-02       Impact factor: 5.115

7.  [Two cases of basal chondroma (author's transl)].

Authors:  T Kitahara; S Morii; Y Miyasaka; T Ohwada; K Yada
Journal:  No Shinkei Geka       Date:  1979-08

8.  Parasellar chondrosarcoma in a patient with Ollier's disease.

Authors:  K Reuter; A L Weber
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

9.  [Magnetic resonance (MR) imaging of chordoma and chondroma in the skull base--differential diagnosis by IR sequence].

Authors:  T Tashiro; Y Inoue; Y Nemoto; M Shakudo; K Mochizuki; S Yahata; T Tada; M Hata; J Oda; Y Onoyama
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1992-05-25

10.  Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.

Authors:  S Ezzat; H S Smyth; L Ramyar; S L Asa
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

View more
  2 in total

1.  Surgical Strategies and Outcomes for Intracranial Chondromas: A Retrospective Study of 17 Cases and Systematic Review.

Authors:  Hongyuan Liu; Qing Cai; Junting Li; Yafei Xue; Yunze Zhang; Zongping Li; Tianzhi Zhao; Yingxi Wu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

2.  Application of MRI images based on Spatial Fuzzy Clustering Algorithm guided by Neuroendoscopy in the treatment of Tumors in the Saddle Region.

Authors:  Peng Zhang; Lingdang Zhang; Rui Zhao
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.